What is the recommended dose of intramuscular epinephrine for cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intramuscular Epinephrine Should NOT Be Used for Cardiac Arrest

Intramuscular epinephrine is inappropriate for cardiac arrest and must never be used; the only acceptable route is intravenous or intraosseous administration of 1 mg (1:10,000 concentration) every 3-5 minutes. 1, 2, 3

Why Intramuscular Administration Fails in Cardiac Arrest

  • Absorption is unpredictable and inadequate during the low-flow or no-flow state of cardiac arrest, making IM delivery ineffective for achieving therapeutic plasma concentrations 4

  • The dose is insufficient – the 0.3-0.5 mg IM dose used for anaphylaxis is far below the 1 mg required for cardiac arrest resuscitation 2, 4

  • Immediate systemic delivery is essential during cardiac arrest because compromised peripheral perfusion prevents reliable drug absorption from muscle tissue 4

Correct Dosing Protocol for Cardiac Arrest

  • Administer 1 mg IV/IO epinephrine (1:10,000 concentration = 0.1 mg/mL) as the standard dose during adult cardiac arrest 1, 2, 3

  • Repeat every 3-5 minutes throughout the resuscitation until return of spontaneous circulation or termination of efforts 1, 2, 3

  • No maximum cumulative dose is defined in current guidelines, though the benefit of continued dosing beyond multiple rounds remains uncertain 3

  • This regimen improves return of spontaneous circulation (ROSC) and survival to hospital admission, though the impact on long-term neurologically intact survival remains controversial 1, 2

Critical Distinction: Anaphylaxis vs. Cardiac Arrest

  • For anaphylaxis WITHOUT cardiac arrest: Give 0.3-0.5 mg IM epinephrine (1:1000 concentration = 1 mg/mL) into the anterolateral thigh, repeated every 5-15 minutes as needed 2, 4

  • When anaphylaxis progresses to cardiac arrest: Immediately abandon the IM protocol and switch to the cardiac arrest regimen of 1 mg IV/IO epinephrine (1:10,000) every 3-5 minutes 2, 4

  • The 1:1000 concentration used for IM anaphylaxis is ten times more concentrated than the 1:10,000 formulation required for IV cardiac arrest dosing; confusing these can cause severe iatrogenic complications 4

High-Dose Epinephrine Is Not Recommended

  • High-dose epinephrine (0.1-0.2 mg/kg) is not recommended for routine use in cardiac arrest 3

  • While high-dose regimens may increase ROSC rates, they do not improve survival to hospital discharge and may worsen post-arrest outcomes through excessive vasoconstriction and myocardial injury 3

  • High-dose epinephrine may be considered only in exceptional circumstances such as beta-blocker or calcium channel blocker overdose 3

Pharmacokinetic Considerations

  • Epinephrine elimination during cardiac arrest is prolonged, with a half-life of approximately 2.6 minutes (range 1.9-4.4 minutes) 5

  • Repeated dosing may lead to accumulation and increased plasma levels, though the optimal plasma concentration during resuscitation remains unknown 5

  • The 3-5 minute dosing interval is based on expert consensus rather than pharmacokinetic data, and no evidence supports altering this interval to improve outcomes 6

Common Pitfalls to Avoid

  • Never use IM epinephrine for cardiac arrest – this route is reserved exclusively for anaphylaxis management 2, 4

  • Do not confuse concentrations – hospitals should stock clearly labeled, pre-filled syringes that differentiate IM (1:1000) from IV/IO (1:10,000) formulations 4

  • Avoid routine high-dose protocols without specific toxicological indications 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Epinephrine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Maximum Epinephrine Dosage in Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pediatric Adrenaline Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.